Erken evrede Total Abdominal Histerektomi + BSO yeterlidir (Evre IA)
Adjuvan tedavi seçenekleri:
Radyoterapi
Kemoterapi
Kemoradyoterapi
Prognostikfaktörler
Risk factors include age, obesity, diabetes, hypertension, polycystic ovary syndrome (PCOS), tamoxifen use, nulliparity, early menarche, late menopause, estrogen-only HRT, and genetic predisposition.
The incidence of endometrial carcinoma has increased over time due to changes in lifestyle habits such as obesity, hormone replacement therapy (HRT), and dietary factors.
Endometrial cancer is the most common gynecological malignancy, accounting for approximately 30% of all cancers of the female reproductive system.
Most patients present with localized disease that has not spread beyond the uterus.
Endometrial cancer is the most common gynecologic malignancy with an increasing incidence rate over time.
In Turkey, it ranks second among gynecological tumors after cervical cancer.
Approximately 15% of cases are diagnosed at an advanced stage when the tumor has invaded adjacent organs or metastasized to distant sites.
There are two types of endometrial cancer: Type I (endometroid) and Type II (non-endometroid).
The majority of endometrial cancers are diagnosed at an early stage due to symptoms such as abnormal vaginal bleeding or discharge.
Approximately 60% of patients are diagnosed at stage I, which means they have only localized disease within the uterus.
Risk factors for endometrial cancer include unopposed estrogen exposure, tamoxifen use, genetic predisposition, and Lynch syndrome.
Type I endometrial carcinoma accounts for about 80% of all cases and includes endometrioid adenocarcinomas, serous papillary carcinomas, clear cell carcinomas, and mixed epithelial/stromal tumors.